Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEBBLE: Preoperative Bintrafusp Alfa in Bladder Cancer
NCT04878250Phase 2Unknown
- Sponsor
- Queen Mary University of London
- Start
- Jun 2021
- Primary completion
- Jul 2023
- Modality
- Immune Checkpoint Inhibitors, Fc-Fusion Proteins
01
Overview
A Phase 2 trial of bintrafusp alfa in urothelial carcinoma of the bladder (UC), sponsored by Queen Mary University of London. Status: unknown.
02
Drugs
bintrafusp alfa
03
Conditions
urothelial carcinoma of the bladder (UC)
Beyond the preview
Go deeper on NCT04878250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04878250.